Nutritional Rehabilitation and Markers of Severity in Anorexia Nervosa
EAT
Τhe Effect of Nutritional rEhabilitation in Patients With Anorexia Nervosa on Markers Associated With Disease severiTy
1 other identifier
observational
13
1 country
1
Brief Summary
The design of this project is a longitudinal trial in patients with Anorexia Nervosa (AN) during in-hospital rehabilitation. Τhe structure of the study, the questionnaires and data protection policy prepared exclusively for our study, have been reviewed and standardised at Institutional Review Boards (Ethics Committees, IRBs,) in Harokopio University of Athens (HUA), Eginition Hospital (EH), Attiko Hospital (AH) and Sismanoglio Hospital (SG). AN is a psychiatric disorder followed by a psychopathologic concerning of body image and very low body weight due to extreme self-starvation. The exact pathogenesis of AN remains unknown with neurobiological, gastrointestinal, neuroendocrinological, immunological, and genetic factors suspected to be implicated. Furthermore, many metabolic traits, biochemical, biological or/and anthropometrical, are manifested during the maintaining effort of patients to achieve lower body weight. Self-inflicted starvation is the primary and essential causation of the pathological outcomes of the disorder. These outcomes involve all biological systems and organs. The role of the immune system in AN is critical as levels of pro-inflammatory cytokines are increased and the immune system is dysregulated. Other contributors to AN pathogenesis have been proposed, such as increased oxidative stress, dysbiosis of the gut microbiota and altered metabolomic profiles. Treatment options for patients with AN constitutes outpatient and inpatient care accordingly with the severity of the disorder. So far, no biomarker has been strongly proposed as an indicator of the disorder's severity or for assessing the progression of the treatment. The purpose of this study is to assess and monitor the nutritional rehabilitation of patients with AN during hospitalization treatment. Throughout the treatment's course, nutrition and feeding process, vital signs, psychopathology and biological samples will be gathered and statistical analysis of these data is expected to reveal potential biomarker/s for monitoring the progression of recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 8, 2022
CompletedFirst Posted
Study publicly available on registry
November 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2023
CompletedMay 20, 2025
October 1, 2024
1.1 years
November 8, 2022
May 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Increase in Body Weight
Increase in body weight as a marker of rehabilitation
Up to three months during inpatient rehabilitation
Secondary Outcomes (8)
Metabolic recovery in patients with AN
Up to three months during inpatient rehabilitation
Changes in ghrelin levels
Up to three months during inpatient rehabilitation
Changes in blood metals and metalloids
Up to three months during inpatient rehabilitation
Changes in leptin levels
Up to three months during inpatient rehabilitation
Changes in IL-6 levels
Up to three months during inpatient rehabilitation
- +3 more secondary outcomes
Study Arms (1)
Anorexia Nervosa (AN)
Anorexia Nervosa patients hospitalized for rehabilitation
Interventions
Hospitalized patients with AN under treatment for rehabilitation
Eligibility Criteria
13 Males and females with AN who are hospitalized for rehabilitation
You may qualify if:
- Patients with Anorexia Nervosa according to the DSM-V (American Psychiatric Association, 2013)
You may not qualify if:
- Antibiotic treatment before and during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Harokopio Universitylead
- National and Kapodistrian University of Athenscollaborator
- Sismanoglio General Hospitalcollaborator
- Attikon Hospitalcollaborator
- National Hellenic Research Foundationcollaborator
Study Sites (1)
Kaliora, Andriana C.
Athens, Attica, Greece
Biospecimen
Fecal samples are used to extract DNA for NGS
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Andriana C. Kaliora
Harokopio University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. in Human Nutrition and Foods
Study Record Dates
First Submitted
November 8, 2022
First Posted
November 25, 2022
Study Start
September 1, 2022
Primary Completion
October 24, 2023
Study Completion
December 24, 2023
Last Updated
May 20, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share